Team IDs Genetic Variant Associated With Breast Cancer Chemo Resistance

A National Cancer Institute-led research team demonstrated that a genetic variation in the manganese superoxide dismutase gene SOD2 can help predict breast cancer patients' outcomes following chemotherapy with a drug called cyclophosphamide.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.